Epidemiology of antimicrobial resistance in bloodstream infections

References

• Centers for Disease Control and Prevention (CDC). Antibiotic resistance threats in the United States. 2013. Available at http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508
   Google Scholar
• O'Neill J (chair). Review on antimicrobial resistance: tackling a crisis for the health and wealth of nations. 2014. Available at http://amr-review.org/
   Google Scholar
• Teillant A, Gandra S, Barter D, Morgan DJ, Laxminarayan R. Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study. Lancet Infect Dis 2015; 15:1429-37; PMID:26482597; http://dx.doi.org/10.1016/S1473-3099(15)00270-4
   PubMed Web of Science ®Google Scholar
• Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 2008; 197:1079-81; PMID:18419525; http://dx.doi.org/10.1086/533452
   PubMed Web of Science ®Google Scholar
• Peterson LR. Bad bugs, no drugs: no ESCAPE revisited. Clin Infect Dis 2009; 49:992; PMID:19694542; http://dx.doi.org/10.1086/605539
   PubMed Web of Science ®Google Scholar
• Paphitou NI. Antimicrobial resistance: action to combat the rising microbial challenges. Int J Antimicrob Agents 2013; 42 Suppl: S25-8; PMID:23684003; http://dx.doi.org/10.1016/j.ijantimicag.2013.04.007
   PubMedGoogle Scholar
• Collignon P, Athukorala PC, Seanayake S, Khan F. Antimicrobial resistance: the major contribution of poor governance and corruption to this growing problem. PLoS One 2015; 10:e0116746; PMID:25786027; http://dx.doi.org/10.1371/journal.pone.0116746
   PubMed Web of Science ®Google Scholar
• World Health Organization. Antimicrobial Resistance. Global Report on Surveillance 2014. Available at http://www.who.int/drugresistance/documents/surveillancereport/en/
   Google Scholar
• European Centre for Disease Prevention and Control (ECDC). Annual epidemiological report 2014. Antimicrobial resistance and healthcare-associated infections. 2015. Available at http://ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-annual-epidemiological-report.pdf.
   Google Scholar
• WHO Regional Office for Europe. Central Asian and Eastern European surveillance of antimicrobial resistance. Ann Rep 2014. Available at http://www.euro.who.int/en/health-topics/disease-prevention/antimicrobial-resistance/antimicrobial-resistance/central-asian-and-eastern-european-surveillance-of-antimicrobial-resistance-caesar
   Google Scholar
• Dawn M., Sievert, Philip Ricks, Jonathan R, Edwards MS, Schneider A, Patel J, Srinivasan A, Kallen A, Limbago B, Fridkin S for the National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol 2013; 34:1-14; PMID:23221186; http://dx.doi.org/10.1086/668770
   PubMed Web of Science ®Google Scholar
• Tong SYC, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 2015; 28:603-61; PMID:26016486; http://dx.doi.org/10.1128/CMR.00134-14
   PubMed Web of Science ®Google Scholar
• de Kraker ME, Davey PG, Grundmann H. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Medicine 2011, 8: e1001104; PMID:22022233; http://dx.doi.org/10.1371/journal.pmed.1001104
   PubMed Web of Science ®Google Scholar
• Johnson AP, Davies J, Guy R, Abernethy J, Sheridan E, Pearson A, Duckworth G. Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. J Antimicrob Chemother 2012; 67:802-9; PMID:22223229; http://dx.doi.org/10.1093/jac/dkr561
   PubMed Web of Science ®Google Scholar
• Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, Ray SM, Harrison LH, Lynfield R, Dumyati G, et al. Health care-associated invasive MRSA infections, 2005–2008. JAMA 2010; 304:641-8; PMID:20699455; http://dx.doi.org/10.1001/jama.2010.1115
   PubMed Web of Science ®Google Scholar
• Jarlier V, Trystram D, Brun-Buisson C, Fournier S, Carbonne A, Marty L, Andremont A, Arlet G, Buu-Hoi A, Carlet J, et al. Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Arch Intern Med 2010; 170:552-9; PMID:20308642; http://dx.doi.org/10.1001/archinternmed.2010.32
   PubMedGoogle Scholar
• EARS-Net: European Centre for Disease Prevention and Control (ECDC), Antimicrobial resistance interactive database (Internet). Stockholm (Sweden): ECDC (cited 2015 Oct 22). Available from http://ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/database/Pages/database.aspx.
   Google Scholar
• McGehee R, Smith CB, Wilcox C, Finland M. Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clindamycin. Am J Med Sci 1968; 256:279-92; PMID:4386950; http://dx.doi.org/10.1097/00000441-196811000-00002
   PubMed Web of Science ®Google Scholar
• Grim SA, Rapp RP, Martin CA, Evans ME. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus. Pharmacotherapy 2005; 25:253-64; PMID:15767239; http://dx.doi.org/10.1592/phco.25.2.253.56956
   PubMed Web of Science ®Google Scholar
• Richter SS, Satola SW, Crispell EK, et al. Detection of Staphylococcus aureus isolates with heterogeneous intermediate-level resistance to vancomycin in the United States. J Clin Microbiol 2011; 49:4203-7; PMID:21976769; http://dx.doi.org/10.1128/JCM.01152-11
   PubMed Web of Science ®Google Scholar
• Jones RN. Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains. Clin Infect Dis 2006; 42 (suppl 1):S13-S24; PMID:16323115; http://dx.doi.org/10.1086/491710
   PubMedGoogle Scholar
• Kalil AC, Van Schooneveld TC, Fey PD, Rupp ME. Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis. JAMA 2014; 312:1552-64; PMID:25321910; http://dx.doi.org/10.1001/jama.2014.6364
   PubMed Web of Science ®Google Scholar
• Chong YP, Park KH, Kim ES, Kim MN, Kim SH, Lee SO, Choi SH, Jeong JY, Woo JH, Kim YS. Clinical and microbiologic analysis of the risk factors for mortality in patients with heterogeneous vancomycin-intermediate Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2015; 59:3541-7; PMID:25845875; http://dx.doi.org/10.1128/AAC.04765-14
   PubMed Web of Science ®Google Scholar
• Sader HS, Jones RN. The activity of daptomycin against wild-type Staphylococcus aureus and strains with reduced susceptibility to vancomycin. Clin Infect Dis 2006; 43:798-9; PMID:16912964; http://dx.doi.org/10.1086/507109
   PubMed Web of Science ®Google Scholar
• Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006; 355:653-65; PMID:16914701; http://dx.doi.org/10.1056/NEJMoa053783
   PubMed Web of Science ®Google Scholar
• Steed ME, Vidaillac C, Rybak MJ. Evaluation of telavancin activity versus daptomycin and vancomycin against daptomycin-nonsusceptible Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model. Antimicrob Agents Chemother 2012; 56:955-9; PMID:22123693; http://dx.doi.org/10.1128/AAC.05849-11
   PubMed Web of Science ®Google Scholar
• Stryjewski ME, Corey GR. Methicillin-resistant Staphylococcus aureus: an evolving pathogen. Clin Infect Dis 2014; 58 (suppl 1):S10-S19; PMID:24343827; http://dx.doi.org/10.1093/cid/cit613
   PubMedGoogle Scholar
• Laupland KB, Church DL. Population-based epidemiology and microbiology of community-onset bloodstream infections. Clin Microbiol Rev 2014; 27:647-4; PMID:25278570; http://dx.doi.org/10.1128/CMR.00002-14
   PubMed Web of Science ®Google Scholar
• van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev 2012; 25:362-86; PMID:22491776; http://dx.doi.org/10.1128/CMR.05022-11
   PubMed Web of Science ®Google Scholar
• Chuang YY, Huang YC. Molecular epidemiology of community associated meticillin-resistant Staphylococcus aureus in Asia. Lancet Infect Dis 2013; 13:698-708; PMID:23827369; http://dx.doi.org/10.1016/S1473-3099(13)70136-1
   PubMed Web of Science ®Google Scholar
• David MZ, Daum RS. Community-associated methicillin resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010; 23:616-87; PMID:20610826; http://dx.doi.org/10.1128/CMR.00081-09
   PubMed Web of Science ®Google Scholar
• Laupland KB, Lyytikainen O, Sogaard M, Kennedy KJ, Knudsen JD, Ostergaard C, Galbraith JC, Valiquette L, Jacobsson G, Collignon P, et al. The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect 2013; 19:465-71; PMID:22616816; http://dx.doi.org/10.1111/j.1469-0691.2012.03903.x
   PubMed Web of Science ®Google Scholar
• Skov RL, Jensen KS. Community-associated meticillin-resistant Staphylococcus aureus as a cause of hospital-acquired infections. J Hosp Infect 2009; 73:364-70; PMID:19786313; http://dx.doi.org/10.1016/j.jhin.2009.07.004
   PubMed Web of Science ®Google Scholar
• Rhee Y, Aroutcheva A, Hota B, Weinstein RA, Popovich KJ. Evolving epidemiology of Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2015; 36:1417-22; PMID:26372679; http://dx.doi.org/10.1017/ice.2015.213
   PubMed Web of Science ®Google Scholar
• Mikulska M, Viscoli C, Orasch C, Livermore DM, Averbuch D, Cordonnier C, Akova M, on behalf of the Fourth European Conference on Infections in Leukemia Group (ECIL-4), a joint venture of EBMT, EORTC, ICHS, ELN and ESGICH/ESCMID. Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients. J Infect 2014 68(4):321-31; PMID:24370562; http://dx.doi.org/10.1016/j.jinf.2013.12.006
   PubMed Web of Science ®Google Scholar
• Mermel LA, Allon M, Bouza E, Craven DE; Flynn P, O'Grady NP, Raad II, Rijnders BJ, Shereretz RJ, Warren DK. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:1-45; PMID:19489710; http://dx.doi.org/10.1086/599376
   PubMed Web of Science ®Google Scholar
• Hope R, Livermore DM, Brick G, Lillie M, Reynolds R; BSAC Working Parties on Resistance Surveillance. Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother 2008; 62 Suppl 2:ii65-74; PMID:18819981
   PubMed Web of Science ®Google Scholar
• May L, Klein EY, Rothman RE, Laxminarayan R. Trends in antibiotic resistance in coagulase negative staphylococci in the United States, 1999 to 2012. Antimicrob Agents Chemother 2014; 58:1404-9; PMID:24342646; http://dx.doi.org/10.1128/AAC.01908-13
   PubMed Web of Science ®Google Scholar
• Gu B1, Kelesidis T, Tsiodras S, Hindler J, Humphries RM. The emerging problem of linezolid-resistant Staphylococcus. J Antimicrob Chemother 2013; 68:4-11; PMID:22949625; http://dx.doi.org/10.1093/jac/dks354
   PubMed Web of Science ®Google Scholar
• Decousser JW, Desroches M, Bourgeois-Nicolaos N, Potier J, Jehl F, Lina G, Cattoir V, Vandenesh F, Doucet-Populaire F; Microbs Study Group. Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections. Int J Antimicrob Agents 2015; 46:622-30; PMID:26453147; http://dx.doi.org/10.1016/j.ijantimicag.2015.07.022
   PubMed Web of Science ®Google Scholar
• Stuart JI, John MA, Milburn S, Diagre D, Wilson B, Hussain Z. Susceptibility patterns of coagulase negative staphylococci to several newer antimicrobial agents in comparison with vancomycin and oxacillin. Int J Antimicrob Agents 2011; 37:248-252; PMID:21295951; http://dx.doi.org/10.1016/j.ijantimicag.2010.11.020
   PubMed Web of Science ®Google Scholar
• El Solh A. Ceftobiprole: a new broad spectrum cephalosporin. Expert Opin Pharmacother 2009; 10:1675-86; PMID:19527192; http://dx.doi.org/10.1517/14656560903048967
   PubMed Web of Science ®Google Scholar
• Kullar R, Sakoulas G, Deresinski S, van Hal SJ. When sepsis persists: a review of MRSA bacteraemia salvage therapy. J Antimicrob Chemother 2016; 71:576-86; PMID:26565015; http://dx.doi.org/10.1093/jac/dkv368
   PubMed Web of Science ®Google Scholar
• Forest Laboratories. Safety and efficacy study of ceftaroline in subjects with Staphylococcus aureus bacteremia or with persistent methicillin-resistant Staphylococcus aureus bacteremia. ClinicalTrials.gov Identifier: NCT01701219. https://clinicaltrials.gov/ct2/show/NCT01701219
   Google Scholar
• Lyytikainen O, Klemets P, Ruutu P, Kaijalainen T, Rantala M, Ollgren J, Nuorti JP. Defining the population-based burden of nosocomial pneumococcal bacteremia. Arch Intern Med 2007; 167:1635-40; PMID:17698686; http://dx.doi.org/10.1001/archinte.167.15.1635]
   PubMedGoogle Scholar
• Haber M, Barskey A, Baughman W, Barker L, Whitney CG, Shaw KM, Orenstein W, Stephens DS. Herd immunity and pneumococcal conjugate vaccine: a quantitative model. Vaccine 2007; 25:5390-8; PMID:17583392; http://dx.doi.org/10.1016/j.vaccine.2007.04.088
   PubMed Web of Science ®Google Scholar
• Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principle and Practice of Infectious Diseases. 8th ed. Philadelphia (USA): Elsevier Saunders; c2015. Chapter 201, Streptococcus pneumonia; p.2310-27.
   Google Scholar
• Hung IF1, Tantawichien T, Tsai YH, Patil S, Zotomayor R. Regional epidemiology of invasive pneumococcal disease in Asian adults: epidemiology, disease burden, serotype distribution, and antimicrobial resistance patterns and prevention. Int J Infect Dis 2013; 17:e364-73; PMID:23416209; http://dx.doi.org/10.1016/j.ijid.2013.01.004
   PubMed Web of Science ®Google Scholar
• Mamishi S, Moradkhani S, Mahmoudi S, Hosseinpour-Sadeghi R, Pourakbari B. Penicillin-resistant trend of Streptococcus pneumoniae in Asia: a systematic review. Iran J Microbiol 2014; 6:198-210; PMID:25802701
   PubMedGoogle Scholar
• Slipczuk L, Codolosa JN, Davila CD, Romero-Corral A, Yun J, Pressman GS, Figueredo VMl. Infective endocarditis epidemiology over five decades: a systematic review. PLoS One 2013; 8:e82665; PMID:24349331; http://dx.doi.org/10.1371/journal.pone.0082665
   PubMed Web of Science ®Google Scholar
• Balletto E, Mikulska M. Bacterial infections in hematopoietic stem cell transplant recipients. Mediterr J Hematol Infect Dis 2015; 7:e2015045; PMID:26185610; http://dx.doi.org/10.4084/mjhid.2015.045
   PubMed Web of Science ®Google Scholar
• Swenson FJ, Rubin SJ. Clinical significance of viridans streptococci isolated from blood cultures. J Clin Microbiol 1982; 15:725-7; PMID:7068840
   PubMed Web of Science ®Google Scholar
• Cordonnier C, Buzyn A, Leverger G, Herbrecht R, Hunault M, Leclercq R, Bastuji-Garin S; Club de Réflexion sur les Infections en Onco-Hématologie. Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy. Clin Infect Dis 2003; 36:149-58; PMID:12522746; http://dx.doi.org/10.1086/345435
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Jones RN, Marshall SA, Edmond MB, Wenzel RP. Nosocomial streptococcal bloodstream infections in the SCOPE program: species occurrence and antimicrobial susceptibility. Diagn Microbiol Infect Dis 1997; 29:259-63; PMID:9458983; http://dx.doi.org/10.1016/S0732-8893(97)00159-4
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Marshall SA, Jones RN. In vitro activity of cefepime and ceftazidime against 197 nosocomial blood stream isolates of streptococci: a multicenter study. Diagn Microbiol Infect Dis 1997; 29:273-6; PMID:9458985; http://dx.doi.org/10.1016/S0732-8893(97)00139-9
   PubMed Web of Science ®Google Scholar
• Arias CA, Murray BE. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol 2012; 10:266-78; PMID:22421879; http://dx.doi.org/10.1038/nrmicro2761
   PubMed Web of Science ®Google Scholar
• O'Driscoll T, Crank CW. Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infection Drug Res 2015; 8:217-30
   PubMed Web of Science ®Google Scholar
• Cattoir V, Leclercq R. Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce? J Antimicrob Chemother 2013; 68:731-42; PMID:23208830; http://dx.doi.org/10.1093/jac/dks469
   PubMed Web of Science ®Google Scholar
• Kazanji N, Gjeorgjievski M, Yadav S, Mertens AN, Lauter C. Monomicrobial vs polymicrobial Clostridium difficile bacteremia: a case report and review of the literature. Am J Med 2015; 128:e19-26; PMID:26071832; http://dx.doi.org/10.1016/j.amjmed.2015.05.014
   PubMed Web of Science ®Google Scholar
• Adler A, Miller-Roll T, Bradenstein R, Block C, Mendelson B, Parizade M, Paitan Y, Schwartz D, Peled N, Carmeli Y, Schwaber MJ. A national survey of the molecular epidemiology of Clostridium difficile in Israel: the dissemination of the ribotype 027 strain with reduced susceptibility to vancomycin and metronidazole. Diagn Microbiol Infect Dis 2015; 83:21-4; PMID:26116225; http://dx.doi.org/10.1016/j.diagmicrobio.2015.05.015
   PubMed Web of Science ®Google Scholar
• Spigaglia P. Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection. Ther Adv Infect Dis 2016; 3:23-42; PMID:26862400
   PubMed Web of Science ®Google Scholar
• Spigaglia P, Barbanti F, Mastrantonio P; European Study Group on Clostridium difficile (ESGCD). Multidrug resistance in European Clostridium difficile clinical isolates. J Antimicrob Chemother 2011; 66:2227-34; PMID:21771851; http://dx.doi.org/10.1093/jac/dkr292
   PubMed Web of Science ®Google Scholar
• Tickler IA, Goering RV, Whitmore JD, Lynn AN, Persing DH, Tenover FC; Healthcare Associated Infection Consortium. Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013. Antimicrob Agents Chemother 2014; 58:4214-8; PMID:24752264; http://dx.doi.org/10.1128/AAC.02775-13
   PubMed Web of Science ®Google Scholar
• D'Andrea MM, Arena F, Pallecchi L, Rossolini GM. CTX-M-type β-lactamases: a successful story of antibiotic resistance. Int J Med Microbiol 2013; 303:305-17; PMID:23490927; http://dx.doi.org/10.1016/j.ijmm.2013.02.008
   PubMed Web of Science ®Google Scholar
• Rossolini GM, D'Andrea MM, Mugnaioli C. The spread of CTX-M-type extended-spectrum beta-lactamases. Clin Microbiol Infect 2008; 14 Suppl 1:33-41; PMID:18154526; http://dx.doi.org/10.1111/j.1469-0691.2007.01867.x
   PubMed Web of Science ®Google Scholar
• Kara Ö, Zarakolu P, Aşçioğlu S, Etgül S, Uz B, Büyükaşik Y, Akova M. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies. Infect Dis (Lond) 2015; 47:686-93; PMID:26024284; http://dx.doi.org/10.3109/23744235.2015.1051105
   PubMed Web of Science ®Google Scholar
• Livermore DM. Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med 2012; 27:128-42; PMID:22707882; http://dx.doi.org/10.3904/kjim.2012.27.2.128
   PubMed Web of Science ®Google Scholar
• Hsueh PR, Badal RE, Hawser SP, Hoban DJ, Bouchillon SK, Ni Y, Paterson DL; 2008 Asia–Pacific SMART Group. Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra- abdominal infections in the Asia-Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Int J Antimicrob Agents 2010; 36:408-14; PMID:20728316; http://dx.doi.org/10.1016/j.ijantimicag.2010.07.002
   PubMed Web of Science ®Google Scholar
• Chaudhuri BN, Rodrigues C, Balaji V, Iyer R, Sekar U, Wattal C, Chitnis DS, Dhole TN, Joshi S. Incidence of ESBL producers amongst Gram-negative bacilli isolated from intra-abdominal infections across India (based on SMART study, 2007 data). J Assoc Physicians India 2011; 59:287-92; PMID:21751604
   PubMedGoogle Scholar
• Sader HS, Flamm RK, Jones RN. Frequency of occurrence and antimicrobial susceptibility of Gram-negative bacteremia isolates in patients with urinary tract infection: results from United States and European hospitals (2009-2011). J Chemother 2014; 26:133-8; PMID:24091000; http://dx.doi.org/10.1179/1973947813Y.0000000121
   PubMed Web of Science ®Google Scholar
• Sader HS, Farrell DJ, Flamm RK, Jones RN. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011). Diagn Microbiol Infect Dis 2014; 78:443-8; PMID:24492025; http://dx.doi.org/10.1016/j.diagmicrobio.2013.11.025
   PubMed Web of Science ®Google Scholar
• Vlieghe ER1, Huang TD, Phe T, Bogaerts P, Berhin C, De Smet B, Peetermans WE, Jacobs JA, Glupczynski Y. Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia. Eur J Clin Microbiol Infect Dis 2015; 34:1223-9; PMID:25717021; http://dx.doi.org/10.1007/s10096-015-2350-9
   PubMed Web of Science ®Google Scholar
• Zhang J, Zheng B, Zhao L, Wei Z, Ji J, Li L, Xiao Y. Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals. BMC Infect Dis 2014; 14:659; PMID:25466590; http://dx.doi.org/10.1186/s12879-014-0659-0
   PubMed Web of Science ®Google Scholar
• Park YS, Bae IK, Kim J, Jeong SH, Hwang SS, Seo YH, Cho YK, Lee K, Kim JM. Risk factors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli bacteremia. Yonsei Med J 2014; 55:467-75; PMID:24532519; http://dx.doi.org/10.3349/ymj.2014.55.2.467
   PubMed Web of Science ®Google Scholar
• Kanoksil M, Jatapai A, Peacock SJ, Limmathurotsakul D. Epidemiology, microbiology and mortality associated with community-acquired bacteremia in northeast Thailand: a multicenter surveillance study. PLoS One 2013; 8:e54714; PMID:23349954; http://dx.doi.org/10.1371/journal.pone.0054714
   PubMed Web of Science ®Google Scholar
• Saltoglu N, Karali R, Yemisen M, Ozaras R, Balkan II, Mete B, Tabak F, Mert A, Hondur N, Ozturk R. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities. Int J Clin Pract 2015; 69:766-70; PMID:25683907; http://dx.doi.org/10.1111/ijcp.12608
   PubMed Web of Science ®Google Scholar
• Hristea A, Olaru ID, Adams-Sapper S, Riley LW. Characterization of ESBL-producing Escherichia coli and Klebsiella pneumoniae from bloodstream infections in three hospitals in Bucharest, Romania: a preliminary study. Infect Dis (Lond) 2015; 47:46-51; PMID:25365029; http://dx.doi.org/10.3109/00365548.2014.959043
   PubMed Web of Science ®Google Scholar
• Paterson DL. Resistance in gram-negative bacteria: enterobacteriaceae. Am J Infect Control 2006; 34 (5 Suppl 1):S20-S28; PMID:16813978; http://dx.doi.org/10.1016/j.ajic.2006.05.238
   PubMed Web of Science ®Google Scholar
• Livermore DM, Hope R, Mushtaq S, Warner M. Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producers. Clin Microbiol Infect 2008; 14 Suppl 1:189-93; PMID:18154546; http://dx.doi.org/10.1111/j.1469-0691.2007.01858.x
   PubMed Web of Science ®Google Scholar
• Guh AY, Bulens SN, Mu Y, Jacob JT, Reno J, Scott J, Wilson LE, Vaeth E, Lynfield R, Shaw KM, et al. Epidemiology of carbapenem-resistant enterobacteriaceae in 7 US communities, 2012-2013. JAMA 2015; 314:1479-87; PMID:26436831; http://dx.doi.org/10.1001/jama.2015.12480
   PubMed Web of Science ®Google Scholar
• Xu A, Zheng B, Xu YC, Huang ZG, Zhong NS, Zhuo C. National epidemiology of carbapenem-resistant and extensively drug-resistant Gram-negative bacteria isolated from blood samples in China in 2013. Clin Microbiol Infect 2016 Feb 1. pii: S1198-743X(15)00870-8. http://dx.doi.org/10.1016/j.cmi.2015.09.015. [Epub ahead of print
   Web of Science ®Google Scholar
• Nordmann P, Poirel L. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect 2014; 20:821-30; PMID:24930781; http://dx.doi.org/10.1111/1469-0691.12719
   PubMed Web of Science ®Google Scholar
• Cornaglia G, Giamarellou H, Rossolini GM. Metallo-beta-lactamases: a last frontier for beta-lactams? Lancet Infect Dis 2011; 11:381-93; PMID:21530894; http://dx.doi.org/10.1016/S1473-3099(11)70056-1
   PubMed Web of Science ®Google Scholar
• Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2016; 16:161-8; PMID:26603172; http://dx.doi.org/10.1016/S1473-3099(15)00424-7
   PubMed Web of Science ®Google Scholar
• Hasman H, Hammerum AM, Hansen F, Hendriksen RS, Olesen B, Agersø Y, Zankari E, Leekitcharoenphon P, Stegger M, Kaas RS, et al. Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. Euro Surveill 2015 Dec 10; 20(49); http://dx.doi.org/10.2807/1560-7917.ES.2015.20.49.30085
   PubMedGoogle Scholar
• Malhotra-Kumar S, Xavier BB, Das AJ, Lammens C, Hoang HT, Pham NT, Goossens H. Colistin-resistant Escherichia coli harbouring mcr-1 isolated from food animals in Hanoi, Vietnam. Lancet Infect Dis 2016 Jan 7. pii: S1473-3099(16)00014-1; http://dx.doi.org/10.1016/S1473-3099(16)00014-1
   Web of Science ®Google Scholar
• Malhotra-Kumar S, Xavier BB, Das AJ, Lammens C, Butaye P, Goossens H. Colistin resistance gene mcr-1 harboured on a multidrug resistant plasmid. Lancet Infect Dis 2016 Jan 7. pii: S1473-3099(16)00012-8. http://dx.doi.org/10.1016/S1473-3099(16)00012-8
   Web of Science ®Google Scholar
• Falgenhauer L, Waezsada SE, Yao Y, Imirzalioglu C, Käsbohrer A, Roesler U, Michael GB, Schwarz S, Werner G, Kreienbrock L, Chakraborty T; RESET consortium. Colistin resistance gene mcr-1 in extended-spectrum β-lactamase-producing and carbapenemase-producing Gram-negative bacteria in Germany. Lancet Infect Dis 2016 Jan 7. pii: S1473-3099(16)00009-8; http://dx.doi.org/10.1016/S1473-3099(16)00009-8
   PubMed Web of Science ®Google Scholar
• Perrin-Guyomard A, Bruneau M, Houée P, Deleurme K, Legrandois P, Poirier C, Soumet C, Sanders P. Prevalence of mcr-1 in commensal Escherichia coli from French livestock, 2007 to 2014. Euro Surveill 2016; 21: pii=30135; http://dx.doi.org/10.2807/1560-7917.ES.2016.21.6.30135
   PubMedGoogle Scholar
• Paterson DL, Harris PN. Colistin resistance: a major breach in our last line of defence. Lancet Infect Dis 2016; 16:132-3; PMID:26603171; http://dx.doi.org/10.1016/S1473-3099(15)00463-6
   PubMed Web of Science ®Google Scholar
• Tse H, Yuen KY. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis 2016; 16:145-6; PMID:26711362; http://dx.doi.org/10.1016/S1473-3099(15)00532-0
   PubMed Web of Science ®Google Scholar
• Webb HE, Granier SA, Marault M, Millemann Y, den Bakker HC, Nightingale KK, Bugarel M, Ison SA, Scott HM, Loneragan GH. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis 2016; 16:144-5; PMID:26711363; http://dx.doi.org/10.1016/S1473-3099(15)00538-1
   PubMed Web of Science ®Google Scholar
• Du H, Chen L, Tang YW, Kreiswirth BN. Emergence of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae. Lancet Infect Dis 2016 Jan 29. pii: S1473-3099(16)00056-6; http://dx.doi.org/10.1016/S1473-3099(16)00056-6
   Web of Science ®Google Scholar
• Stoesser N, Mathers AJ, Moore CE, Day NP, Crook DW. Colistin resistance gene mcr-1 and pHNSHP45 plasmid in human isolates of Escherichia coli and Klebsiella pneumoniae. Lancet Infect Dis 2016 Jan 7. pii: S1473-3099(16)00010-4. http://dx.doi.org/10.1016/S1473-3099(16)00010-4
   PubMed Web of Science ®Google Scholar
• Yao X, Doi Y, Zeng L, Lv L, Liu JH. Carbapenem-resistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1. Lancet Infect Dis 2016 Jan 29. pii: S1473-3099(16)00057-8. http://dx.doi.org/10.1016/S1473-3099(16)00057-8
   Web of Science ®Google Scholar
• Huang CC, Chen YS, Toh HS, Lee YL, Liu YM, Ho CM, Lu PL, Liu CE, Chen YH, Wang JH, et al. Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010. Int J Antimicrob Agents 2012; 40 Suppl: S4-10; PMID:22749058; http://dx.doi.org/10.1016/S0924-8579(12)70003-1
   PubMed Web of Science ®Google Scholar
• Cantón R, Akova M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Miriagou V, Naas T, Rossolini GM, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 2012; 18:413-31; http://dx.doi.org/10.1111/j.1469-0691.2012.03821.x
   PubMed Web of Science ®Google Scholar
• Hu L, Zhong Q, Shang Y, Wang H, Ning C, Li Y, Hang Y, Xiong J, Wang X, Xu Y, et al. The prevalence of carbapenemase genes and plasmid-mediated quinolone resistance determinants in carbapenem-resistant Enterobacteriaceae from five teaching hospitals in central China. Epidemiol Infect 2014; 142:1972-7; PMID:24252194; http://dx.doi.org/10.1017/S0950268813002975
   PubMed Web of Science ®Google Scholar
• Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, Cornaglia G, Garau J, Gniadkowski M, Hayden MK, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 2013; 13:785-96; PMID:23969216; http://dx.doi.org/10.1016/S1473-3099(13)70190-7
   PubMed Web of Science ®Google Scholar
• Tseng IL, Liu YM, Wang SJ, Yeh HY, Hsieh CL, Lu HL, Tseng YC, Mu JJ, et al. Emergence of carbapenemase producing Klebsiella pneumonia and spread of KPC-2 and KPC-17 in Taiwan: a nationwide study from 2011 to 2013. PLoS One 2015; 10: e0138471; PMID:26384242; http://dx.doi.org/10.1371/journal.pone.0138471
   PubMed Web of Science ®Google Scholar
• Poirel L, Héritier C, Tolün V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004; 48:15-22; PMID:14693513; http://dx.doi.org/10.1128/AAC.48.1.15-22.2004
   PubMed Web of Science ®Google Scholar
• Carrer A, Poirel L, Eraksoy H, Cagatay AA, Badur S, Nordmann P. Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrob Agents Chemother 2008; 52:2950-54; PMID:18519712; http://dx.doi.org/10.1128/AAC.01672-07
   PubMed Web of Science ®Google Scholar
• Gulmez D, Woodford N, Palepou MF, Mushtaq S, Metan G, Yakupogullari Y, Kocagoz S, Uzun O, Hascelik G, Livermore DM, et al. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Int J Antimicrob Agents 2008; 31:523-6; PMID:18339523; http://dx.doi.org/10.1016/j.ijantimicag.2008.01.017
   PubMed Web of Science ®Google Scholar
• Alp E, Perçin D, Colakoğlu S, Durmaz S, Kürkcü CA, Ekincioğlu P, Güneş T, et al. Molecular characterization of carbapenem-resistant Klebsiella pneumoniae in a tertiary university hospital in Turkey. J Hosp Infect 2013; 84:178-80; PMID:23623803; http://dx.doi.org/10.1016/j.jhin.2013.03.002
   PubMed Web of Science ®Google Scholar
• Aktas Z, Kayacan CB, Schneider I, Can B, Midilli K, Bauernfeind A. Carbapenem-hydrolyzing oxacillinase OXA-48 persists in Klebsiella pneumoniae in Istanbul, Turkey. Chemotherapy 2008; 54:101-6; PMID:18303258; http://dx.doi.org/10.1159/000118661
   PubMed Web of Science ®Google Scholar
• Dortet L, Poirel L, Nordmann P. Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria. Biomed Res Int 2014; 249856; PMID:24790993
   PubMed Web of Science ®Google Scholar
• Logan LK, Renschler JP, Gandra S, Weinstein RA, Laxminarayan R, for the Centers for Disease Control and Prevention Epicenters Program. Carbapenem-resistant Enterobacteriaceae in children, United States, 1999–2012. Emerging Infect Dis 2015; 21:2014-21; PMID:26486124; http://dx.doi.org/10.3201/eid2111.150548
   PubMed Web of Science ®Google Scholar
• Monaco M, Giani T, Raffone M, Arena F, Garcia-Fernandez A, Pollini S; Network EuSCAPE-Italy, Grundmann H, Pantosti A, Rossolini GM, et al. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill 2014; 19:pii: 20939; PMID:25358041; http://dx.doi.org/10.2807/1560-7917.ES2014.19.42.20939
   PubMedGoogle Scholar
• Giacobbe DR, Del Bono V, Trecarichi EM, De Rosa FG, Giannella M, Bassetti M, Bartoloni A, Losito AR, Corcione S, Bartoletti M, et al. Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study. Clin Microbiol Infect 2015; 21:1106.e1-8; PMID:26278669
   PubMedGoogle Scholar
• Bertrand X, Dowzicky MJ. Antimicrobial susceptibility among gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the Tigecycline Evaluation and Surveillance Trial. Clin Ther 2012; 34:124-37; PMID:22154196; http://dx.doi.org/10.1016/j.clinthera.2011.11.023
   PubMed Web of Science ®Google Scholar
• Kolayli F, Gacar G, Karadenizli A, Sanic A, Vahaboglu H. PER-1 is still widespread in Turkish hospitals among Pseudomonas aeruginosa and Acinetobacter spp. FEMS Microbiol Lett 2005; 15:241-5; http://dx.doi.org/10.1016/j.femsle.2005.06.012
   Web of Science ®Google Scholar
• Potron A, Poirel L, Nordmann P. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology. Int J Antimicrob Agents 2015; 45:568-85; PMID:25857949; http://dx.doi.org/10.1016/j.ijantimicag.2015.03.001
   PubMed Web of Science ®Google Scholar
• Jean SS, Lee WS, Yu KW, Liao CH, Hsu CW, Chang FY, Ko WC, Chen RJ, Wu JJ, Chen YH, et al. Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART). J Microbiol Immunol Infect 2015 Jan 10. pii: S1684-1182(15)00021-3. [Epub ahead of print]
   Google Scholar
• Garnacho-Montero J, Dimopoulos G, Poulakou G, Akova M, Cisneros JM, De Waele J, Petrosillo N, Seifert H, Timsit JF, Vila J, et al. Task force on management and prevention of Acinetobacter baumannii infections in the ICU. Intensive Care Med 2015; 41:2057-75; PMID:26438224; http://dx.doi.org/10.1007/s00134-015-4079-4
   PubMed Web of Science ®Google Scholar
• Roca I, Mosqueda N, Altun B, Espinal P, Akova M, Vila J. Molecular characterization of NDM-1-producing Acinetobacter pittii isolated from Turkey in 2006. J Antimicrob Chemother 2014; 69:3437-8; PMID:25096072; http://dx.doi.org/10.1093/jac/dku306
   PubMed Web of Science ®Google Scholar
• Zander E, Fernandez-Gonzalez A, Schleicher X, Dammhayn C, Kamolvit W, Seifert H, Higgins PG. Worldwide dissemination of acquired carbapenem-hydrolysing class D beta-lactamases in Acinetobacter spp. other than Acinetobacter baumannii. Int J Antimicrob Agents 2014; 43:375-7; PMID:24612983; http://dx.doi.org/10.1016/j.ijantimicag.2014.01.012
   PubMed Web of Science ®Google Scholar
• Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006; 12:826-36; PMID:16882287; http://dx.doi.org/10.1111/j.1469-0691.2006.01456.x
   PubMed Web of Science ®Google Scholar
• Reid GE, Grim SA, Aldeza CA, Janda WM, Clark NM. Rapid development of Acinetobacter baumannii resistance to tigecycline. Pharmacotherapy 2007; 27:1198-201; PMID:17655518; http://dx.doi.org/10.1592/phco.27.8.1198
   PubMed Web of Science ®Google Scholar
• Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, Cohen J, Findlay D, Gyssens I, Heure OE, et al. The global threat of antimicrobial resistance: science for intervention. New Microbes New Infect 2015; 6:22-9; PMID:26029375; http://dx.doi.org/10.1016/j.nmni.2015.02.007
   PubMedGoogle Scholar
• Wellington EM, Boxall AB, Cross P, Feil EJ, Gaze WH, Hawkey PM, et al. The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteria. Lancet Infect Dis 2013; 13:155-65; PMID:23347633; http://dx.doi.org/10.1016/S1473-3099(12)70317-1
   PubMed Web of Science ®Google Scholar
• Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, Laxminarayan R. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis 2014; 14:742-50; PMID:25022435; http://dx.doi.org/10.1016/S1473-3099(14)70780-7
   PubMed Web of Science ®Google Scholar
• Versporten A, Bolokhovets G, Ghazaryan L, Abilova V, Pyshnik G, Spasojevic T, Korinteli I, Raka L, Kambaralieva B, Cizmovic L, et al; WHO/Europe-ESAC Project Group. Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe. Lancet Infect Dis 2014; 14:381-7; PMID:24657114; http://dx.doi.org/10.1016/S1473-3099(14)70071-4
   PubMed Web of Science ®Google Scholar
• Center for Disease Dynamics, Economics & Policy. State of the World's Antibiotics, 2015. CDDEP: Washington, D.C., 2015
   Google Scholar
• Bruce J, MacKenzie FM, Cookson B, Mollison J, van der Meer JW, Krcmery V, Gould IM; ARPAC Steering Group. Antibiotic stewardship and consumption: findings from a pan-European hospital study. J Antimicrob Chemother 2009; 64:853-60; PMID:19675012; http://dx.doi.org/10.1093/jac/dkp268
   PubMed Web of Science ®Google Scholar
• Hansen S, Zingg W, Ahmad R, Kyratsis Y, Behnke M, Schwab F, Pittet D, Gastmeier P; PROHIBIT study group. Organization of infection control in European hospitals. J Hosp Infect 2015; 91:338-45; PMID:26542950; http://dx.doi.org/10.1016/j.jhin.2015.07.011
   PubMed Web of Science ®Google Scholar